# PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.

> **NCT07448506** · PHASE3 · COMPLETED · sponsor: **Laboratorios Richmond S.A.C.I.F.** · enrollment: 50 (actual)

## Conditions studied

- High Blood Pressure (& [Essential Hypertension])

## Interventions

- **DRUG:** Treatment with nifedipine

## Key facts

- **NCT ID:** NCT07448506
- **Lead sponsor:** Laboratorios Richmond S.A.C.I.F.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-09
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-08-13
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448506, "PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07448506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*